Present status and future direction of clinical trials in advanced endometrial carcinoma

nork Homesley, Howard D.
Argitaratua 2008

Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endom...

nork Ballard, Karen S., Homesley, Howard D., Hodson, Charles, Presant, Cary A., Rutledge, James, Hallquist, Allan, Perree, Mathieu
Argitaratua 2010

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study

nork Hensley, Martee L., Blessing, John A., DeGeest, Koen, Abulafia, Ovadia, Rose, Peter G., Homesley, Howard D.
Argitaratua 2008

Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response

nork Salom, Emery, Penalver, Manuel, Homesley, Howard, Burrell, Matthew, Garrett, Audrey, Presant, Cary A, Rutledge, James, Chernick, Michael, Hallquist, Allan, Perree, Mathieu
Argitaratua 2012

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced...

nork Spirtos, Nick M., Enserro, Danielle, Homesley, Howard D., Gibbons, Susan K., Cella, David, Morris, Robert T., DeGeest, Koen, Lee, Roger B., Miller, David S.
Argitaratua izan da Gynecol Oncol (2019)

A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study()

nork Burton, Elizabeth R., Brady, Mark, Homesley, Howard D., Rose, Peter G., Nakamura, Toshiaki, Kesterson, Joshua P., Rotmensch, Jacob, Thigpen, J. Tate, Van Le, Linda
Argitaratua izan da Gynecol Oncol (2015)

A Randomized Phase III Trial in Advanced Endometrial Carcinoma of Surgery and Volume Directed Radiation Followed by Cisplatin and Doxorubicin with or without Paclitaxel: A Gynecolo...

nork Homesley, Howard D., Filiaci, Virginia, Gibbons, Susan K., Long, Harry J., Cella, David, Spirtos, Nick M., Morris, Robert T., DeGeest, Koen, Lee, Roger, Montag, Anthony
Argitaratua izan da Gynecol Oncol (2008)

Patient Reported Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: A Gynecologic Oncology Group Study

nork Monk, Bradley J., Huang, Helen Q., Burger, Robert A., Mannel, Robert S., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Liang, Sharon X., Wenzel, Lari
Argitaratua 2012

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

nork Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Argitaratua izan da Gynecol Oncol (2015)

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

nork Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Argitaratua 2014

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

nork Tewari, Krishnansu S., Burger, Robert A., Enserro, Danielle, Norquist, Barbara M., Swisher, Elizabeth M., Brady, Mark F., Bookman, Michael A., Fleming, Gini F., Huang, Helen, Homesley, Howard D., Fowler, Jeffrey M., Greer, Benjamin E., Boente, Matthew, Liang, Sharon X., Ye, Chenglin, Bais, Carlos, Randall, Leslie M., Chan, John K., Ferriss, J. Stuart, Coleman, Robert L., Aghajanian, Carol, Herzog, Thomas J., DiSaia, Philip J., Copeland, Larry J., Mannel, Robert S., Birrer, Michael J., Monk, Bradley J.
Argitaratua izan da J Clin Oncol (2019)